New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin.

Suppr

超能文献

作者信息

Slayton R E, Shnider B I, Elias E, Horton J, Perlia C P

出版信息

Clin Pharmacol Ther. 1971 Sep-Oct;12(5):833-7. doi: 10.1002/cpt1971125833.

DOI:10.1002/cpt1971125833

PMID:4936148

Abstract

摘要

相似文献

New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin.

Clin Pharmacol Ther. 1971 Sep-Oct;12(5):833-7. doi: 10.1002/cpt1971125833.

Mithramycin treatment of hypercalcemia.

Cancer. 1970 Feb;25(2):389-94. doi: 10.1002/1097-0142(197002)25:2<389::aid-cncr2820250217>3.0.co;2-x.

Mithramycin treatment of malignant hypercalcaemia.

Br Med J. 1968 Jul 20;3(5611):167-8. doi: 10.1136/bmj.3.5611.167.

Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma.

N Engl J Med. 1970 Sep 17;283(12):634-6. doi: 10.1056/NEJM197009172831206.

Hypercalcemic crisis in neoplastic diseases: management with mithramycin.

Surgery. 1972 Apr;71(4):631-5.

The relation between serum calcium and tumor metastases.

Surg Gynecol Obstet. 1969 Feb;128(2):369-74.

[Treatment of hypercalcemia using mithramycin].

J Urol Nephrol (Paris). 1975 Apr-May;81(4-5):326-34.

Combined calcitonin and oral phosphate treatment for hypercalcemia in multiple myeloma.

Arch Intern Med. 1977 Jul;137(7):914-6.

[Recent advances on the thyrocalcitonin].

Ann Endocrinol (Paris). 1968 Sep-Oct;29(5):563-75.

[Treatment of hypercalcemia with mithramycin].

Rev Rhum Mal Osteoartic. 1975 Feb;42(2):93-6.

引用本文的文献

Comparative tolerability of drug therapies for hypercalcaemia of malignancy.

Drug Saf. 1999 Nov;21(5):389-406. doi: 10.2165/00002018-199921050-00004.

Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Drugs. 1993 Oct;46(4):594-617. doi: 10.2165/00003495-199346040-00003.

Management of severe hypercalcaemia.

Br Med J. 1980 Jan 26;280(6209):204-5.

Treatment of hypercalcaemia associated with malignancy.

Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):812-3. doi: 10.1136/bmj.288.6420.812.

Disequilibrium hypercalcaemia.

Br Med J (Clin Res Ed). 1983 Jan 29;286(6362):326-7. doi: 10.1136/bmj.286.6362.326.

Drug interferences with clinical laboratory tests.

Drugs. 1982 Jul;24(1):24-63. doi: 10.2165/00003495-198224010-00002.

[Ectopic paraneoplastic endocrinopathies associated with water-electrolyte balance disorders].

Klin Wochenschr. 1973 Apr 15;51(8):361-76. doi: 10.1007/BF01468084.

Drugs for disorders of bone: pharmacological and clinical considerations.

Drugs. 1974;8(4):250-89. doi: 10.2165/00003495-197408040-00003.

Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Eur J Clin Pharmacol. 1986;31(1):27-31. doi: 10.1007/BF00870981.

Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.

Br Med J (Clin Res Ed). 1986 Mar 1;292(6520):583-6. doi: 10.1136/bmj.292.6520.583.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin.

Clin Pharmacol Ther. 1971 Sep-Oct;12(5):833-7. doi: 10.1002/cpt1971125833.

Mithramycin treatment of hypercalcemia.

Cancer. 1970 Feb;25(2):389-94. doi: 10.1002/1097-0142(197002)25:2<389::aid-cncr2820250217>3.0.co;2-x.

Mithramycin treatment of malignant hypercalcaemia.

Br Med J. 1968 Jul 20;3(5611):167-8. doi: 10.1136/bmj.3.5611.167.

Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma.

N Engl J Med. 1970 Sep 17;283(12):634-6. doi: 10.1056/NEJM197009172831206.

Hypercalcemic crisis in neoplastic diseases: management with mithramycin.

Surgery. 1972 Apr;71(4):631-5.

The relation between serum calcium and tumor metastases.

Surg Gynecol Obstet. 1969 Feb;128(2):369-74.

[Treatment of hypercalcemia using mithramycin].

J Urol Nephrol (Paris). 1975 Apr-May;81(4-5):326-34.

Combined calcitonin and oral phosphate treatment for hypercalcemia in multiple myeloma.

Arch Intern Med. 1977 Jul;137(7):914-6.

[Recent advances on the thyrocalcitonin].

Ann Endocrinol (Paris). 1968 Sep-Oct;29(5):563-75.

[Treatment of hypercalcemia with mithramycin].

Rev Rhum Mal Osteoartic. 1975 Feb;42(2):93-6.

引用本文的文献

Comparative tolerability of drug therapies for hypercalcaemia of malignancy.

Drug Saf. 1999 Nov;21(5):389-406. doi: 10.2165/00002018-199921050-00004.

Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Drugs. 1993 Oct;46(4):594-617. doi: 10.2165/00003495-199346040-00003.

Management of severe hypercalcaemia.

Br Med J. 1980 Jan 26;280(6209):204-5.

Treatment of hypercalcaemia associated with malignancy.

Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):812-3. doi: 10.1136/bmj.288.6420.812.

Disequilibrium hypercalcaemia.

Br Med J (Clin Res Ed). 1983 Jan 29;286(6362):326-7. doi: 10.1136/bmj.286.6362.326.

Drug interferences with clinical laboratory tests.

Drugs. 1982 Jul;24(1):24-63. doi: 10.2165/00003495-198224010-00002.

[Ectopic paraneoplastic endocrinopathies associated with water-electrolyte balance disorders].

Klin Wochenschr. 1973 Apr 15;51(8):361-76. doi: 10.1007/BF01468084.

Drugs for disorders of bone: pharmacological and clinical considerations.

Drugs. 1974;8(4):250-89. doi: 10.2165/00003495-197408040-00003.

Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Eur J Clin Pharmacol. 1986;31(1):27-31. doi: 10.1007/BF00870981.

Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.

Br Med J (Clin Res Ed). 1986 Mar 1;292(6520):583-6. doi: 10.1136/bmj.292.6520.583.